Premium Nahrungsergänzungsmittel | artgerecht

Carbamoyl Phosphate – Function and Clinical Significance

Carbamoyl phosphate is a high-energy biochemical intermediate that plays a central role in the urea cycle and pyrimidine biosynthesis within cellular metabolism.

Regular tips about health Regular tips about health

Things worth knowing about "Carbamoyl Phosphate"

Carbamoyl phosphate is a high-energy biochemical intermediate that plays a central role in the urea cycle and pyrimidine biosynthesis within cellular metabolism.

What is Carbamoyl Phosphate?

Carbamoyl phosphate (also written as carbamyl phosphate) is a high-energy, chemically unstable compound belonging to the group of phosphorylated organic molecules. It contains a carbamoyl group (-CO-NH₂) linked to a phosphate group and serves as a critical intermediate in two fundamental metabolic pathways: the urea cycle and pyrimidine biosynthesis. It is synthesized in both the mitochondria and the cytoplasm and is essential for detoxifying ammonia and for the synthesis of nucleotides.

Synthesis and Enzymes

Carbamoyl phosphate is produced by specific enzymes depending on its location within the cell:

Carbamoyl Phosphate Synthetase I (CPS I): Located in the mitochondria of liver cells, this enzyme catalyzes the reaction of ammonia (NH₃), carbon dioxide (CO₂), and two molecules of ATP to form carbamoyl phosphate. This is the first and rate-limiting step of the urea cycle. CPS I requires N-acetylglutamate as an allosteric activator.
Carbamoyl Phosphate Synthetase II (CPS II): Found in the cytoplasm of virtually all cells, this enzyme uses glutamine rather than free ammonia as the nitrogen donor and produces carbamoyl phosphate for pyrimidine biosynthesis. It does not require N-acetylglutamate as a cofactor.

Role in the Urea Cycle

The urea cycle takes place primarily in the liver and serves to detoxify ammonia, which is generated during the breakdown of nitrogen-containing compounds such as amino acids. In high concentrations, ammonia is toxic to cells. Carbamoyl phosphate produced by CPS I condenses with ornithine in the mitochondria to form citrulline, the next intermediate in the cycle. Through several additional enzymatic steps, urea is ultimately formed and excreted by the kidneys.

Role in Pyrimidine Biosynthesis

In the cytoplasm, carbamoyl phosphate generated by CPS II is used in the de novo synthesis of pyrimidines. Pyrimidines are structural components of nucleotides and are therefore essential for the building of DNA and RNA. Carbamoyl phosphate reacts with aspartate to form carbamoyl aspartate, a precursor to the pyrimidine ring structure. This biosynthetic pathway is crucial for cell division and growth.

Clinical Relevance

Disorders affecting carbamoyl phosphate metabolism can lead to serious medical conditions:

CPS I Deficiency: A rare, autosomal recessive enzyme defect resulting in severe hyperammonemia (elevated blood ammonia levels). Newborns may present with lethargy, vomiting, seizures, and coma. Without treatment, the condition is life-threatening.
N-Acetylglutamate Synthase (NAGS) Deficiency: Since N-acetylglutamate is the essential activator of CPS I, a deficiency of this enzyme also leads to hyperammonemia with similar clinical consequences.
Ornithine Transcarbamylase (OTC) Deficiency: The most common urea cycle disorder, inherited in an X-linked manner. Because the step immediately following carbamoyl phosphate formation is impaired, carbamoyl phosphate accumulates and is redirected into pyrimidine biosynthesis, resulting in elevated urinary orotic acid levels.

Diagnosis

The following diagnostic methods are used to evaluate disorders of carbamoyl phosphate metabolism:

Measurement of plasma ammonia levels
Determination of plasma amino acids (e.g., glutamine, citrulline, arginine)
Analysis of urinary organic acids (e.g., orotic acid)
Enzyme activity assays in liver biopsies or erythrocytes
Molecular genetic testing to identify causative gene mutations

Treatment Approaches

Management of disorders related to impaired carbamoyl phosphate metabolism includes the following strategies:

Low-protein diet: Reducing protein intake to decrease ammonia production
Nitrogen scavengers (e.g., sodium phenylbutyrate, sodium phenylacetate): These compounds bind nitrogen and allow its excretion through alternative pathways
Arginine and citrulline supplementation: To maintain urea cycle function
N-carbamylglutamate: A synthetic analogue of N-acetylglutamate used therapeutically in CPS I deficiency and NAGS deficiency
Liver transplantation: A curative option in severe cases

References

Häberle, J. et al. - Suggested guidelines for the diagnosis and management of urea cycle disorders - Orphanet Journal of Rare Diseases, 7:32 (2012), PubMed PMID: 22642880
Caldovic, L., Tuchman, M. - N-acetylglutamate and its changing role through evolution - Biochemical Journal, 372(Pt 2):279-290 (2003), PubMed PMID: 12633501
Stryer, L., Berg, J. M., Tymoczko, J. L. - Biochemistry, 8th Edition, W. H. Freeman and Company, New York (2015)

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.